Resverlogix (RVX) Competitors

C$0.05

0.00 (0.00%)

(As of 07/26/2024 ET)

Stock Analysis Chart Competitors Earnings Headlines Insider Trades

RVX vs. EMH, HBP, PMN, COV, DMT, MBX, IBT, ACST, LTY, and GSD

Should you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include Emerald Health Therapeutics (EMH), Helix BioPharma (HBP), ProMIS Neurosciences (PMN), Covalon Technologies (COV), Small Pharma (DMT), Microbix Biosystems (MBX), IBEX Technologies (IBT), Acasti Pharma (ACST), Liberty Biopharma (LTY), and Devonian Health Group (GSD). These companies are all part of the "biotechnology" industry.

Resverlogix vs.

Emerald Health Therapeutics (CVE:EMH) and Resverlogix (TSE:RVX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

: In the previous week, Resverlogix had 1 more articles in the media than Emerald Health Therapeutics. MarketBeat recorded 1 mentions for Resverlogix and 0 mentions for Emerald Health Therapeutics. Resverlogix's average media sentiment score of 0.00 equaled Emerald Health Therapeutics'average media sentiment score.
Company Overall Sentiment
Emerald Health Therapeutics Neutral
Resverlogix Neutral
: Company Net Margins Return on Equity Return on Assets
Emerald Health Therapeutics N/A N/A N/A
Resverlogix N/A N/A -44.23%
: Resverlogix received 169 more outperform votes than Emerald Health Therapeutics when rated by MarketBeat users. Likewise, 84.01% of users gave Resverlogix an outperform vote while only 57.09% of users gave Emerald Health Therapeutics an outperform vote.
Company Underperform Outperform
Emerald Health Therapeutics Outperform Votes
141
57.09%
Underperform Votes
106
42.91%
Resverlogix Outperform Votes
310
84.01%
Underperform Votes
59
15.99%
: Resverlogix has lower revenue, but higher earnings than Emerald Health Therapeutics. Resverlogix is trading at a lower price-to-earnings ratio than Emerald Health Therapeutics, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Emerald Health Therapeutics C$13.02M 4.02 -C$142.70M -C$0.70 -0.37
Resverlogix N/A N/A -C$16.74M -C$0.08 -0.63
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Emerald Health Therapeutics
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Resverlogix
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Overall Sentiment
Emerald Health Therapeutics	Neutral
Resverlogix	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Emerald Health Therapeutics	N/A	N/A	N/A
Resverlogix	N/A	N/A	-44.23%

Company	Underperform	Outperform
Emerald Health Therapeutics	Outperform Votes 141 57.09%	Underperform Votes 106 42.91%
Resverlogix	Outperform Votes 310 84.01%	Underperform Votes 59 15.99%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Emerald Health Therapeutics	C$13.02M	4.02	-C$142.70M	-C$0.70	-0.37
Resverlogix	N/A	N/A	-C$16.74M	-C$0.08	-0.63

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Emerald Health Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Resverlogix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Resverlogix beats Emerald Health Therapeutics on 5 of the 8 factors compared between the two stocks.

Ad Weiss Ratings

Nvidia’s Quiet $1 Trillion Pivot

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.

Get Resverlogix News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RVX vs. The Competition

Export to Excel

Metric	Resverlogix	Biotechnology Industry	Medical Sector	TSE Exchange
Market Cap	C$13.74M	C$149.97M	C$5.35B	C$5.51B
Dividend Yield	7.02%	3.49%	2.72%	5.95%
P/E Ratio	-0.63	91.50	112.08	24.58
Price / Sales	N/A	17,674.37	2,081.09	1,611.47
Price / Cash	132.50	11.86	35.85	80.06
Price / Book	-0.19	6.65	4.94	3.50
Net Income	-C$16.74M	-C$19.95M	C$112.13M	C$287.84M
7 Day Performance	N/A	1.01%	2.73%	0.75%
1 Month Performance	N/A	6.12%	6.97%	4.99%
1 Year Performance	N/A	12.25%	11.21%	28.43%

Resverlogix Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EMH Emerald Health Therapeutics	0 of 5 stars 0.00 / 5 stars	C$0.26 -3.8%	N/A	+0.0%	C$52.28M	C$13.02M	-0.37	161
HBP Helix BioPharma	0 of 5 stars 0.00 / 5 stars	C$0.23 -4.3%	N/A	+7.1%	C$51.62M	N/A	-7.50	9	Gap Down
PMN ProMIS Neurosciences	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	C$51.48M	C$7,558.00	-1.78	6	Gap Up High Trading Volume
COV Covalon Technologies	0 of 5 stars 0.00 / 5 stars	C$2.07 -1.4%	N/A	+15.3%	C$51.07M	C$25.07M	-10.89	N/A
DMT Small Pharma	0 of 5 stars 0.00 / 5 stars	C$0.15 -6.3%	N/A	+114.3%	C$50.37M	C$-1,162.00	-2.14	13	News Coverage Gap Down High Trading Volume
MBX Microbix Biosystems	0 of 5 stars 0.00 / 5 stars	C$0.33 -3.0%	N/A	-1.6%	C$44.66M	C$22.42M	10.83	N/A	News Coverage
IBT IBEX Technologies	0 of 5 stars 0.00 / 5 stars	C$1.44 flat	N/A	+39.8%	C$35.29M	C$8M	9.60	N/A
ACST Acasti Pharma	0 of 5 stars 0.00 / 5 stars	C$0.58 +1.8%	N/A	+0.0%	C$25.87M	C$115,000.00	-1.07	32
LTY Liberty Biopharma	0 of 5 stars 0.00 / 5 stars	C$2.00 +∞	N/A	+0.0%	C$21.54M	N/A	-12.66	N/A	News Coverage Gap Up
GSD Devonian Health Group	0 of 5 stars 0.00 / 5 stars	C$0.14 +7.7%	N/A	-30.9%	C$20.75M	C$5.03M	-7.00	6	Gap Up